Co-Authors
This is a "connection" page, showing publications co-authored by Michel Drancourt and Philippe Brouqui.
Connection Strength
1.729
-
Old antibiotics for emerging multidrug-resistant/extensively drug-resistant tuberculosis (MDR/XDR-TB). Int J Antimicrob Agents. 2017 May; 49(5):554-557.
Score: 0.709
-
COVID-19 Management at IHU Méditerranée Infection: A One-Year Experience. J Clin Med. 2021 Jun 29; 10(13).
Score: 0.238
-
Evaluating the serological status of COVID-19 patients using an indirect immunofluorescent assay, France. Eur J Clin Microbiol Infect Dis. 2021 Feb; 40(2):361-371.
Score: 0.228
-
Role of second-line injectable antituberculosis drugs in the treatment of MDR/XDR tuberculosis. Int J Antimicrob Agents. 2017 Aug; 50(2):252-254.
Score: 0.180
-
Respiratory tract isolation of Mycobacterium europaeum following influenza infection in an immunocompromised patient: a case report. J Med Case Rep. 2014 Dec 25; 8:463.
Score: 0.152
-
Outcomes of 3,737 COVID-19 patients treated with hydroxychloroquine/azithromycin and other regimens in Marseille, France: A retrospective analysis. Travel Med Infect Dis. 2020 Jul - Aug; 36:101791.
Score: 0.056
-
Early treatment of COVID-19 patients with hydroxychloroquine and azithromycin: A retrospective analysis of 1061 cases in Marseille, France. Travel Med Infect Dis. 2020 May - Jun; 35:101738.
Score: 0.055
-
Clinical and microbiological effect of a combination of hydroxychloroquine and azithromycin in 80 COVID-19 patients with at least a six-day follow up: A pilot observational study. Travel Med Infect Dis. 2020 Mar - Apr; 34:101663.
Score: 0.055
-
Malaria, tuberculosis and HIV: what's new? Contribution of the Institut Hospitalo-Universitaire Méditerranée Infection in updated data. New Microbes New Infect. 2018 Nov; 26:S23-S30.
Score: 0.048
-
Mediterranean spotted fever in Marseille: descriptive epidemiology and the influence of climatic factors. Eur J Epidemiol. 1992 Mar; 8(2):192-7.
Score: 0.008